The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Molecular Psychiatry
Institutions: Ludwig-Maximilians-Universität München, University of Münster
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2049808835
